exRNAdisease

Entry Detail

---



General Information

Database ID: exR0263413 RNA Name: hsa-miR-654-5p RNA Type: miRNA Chromosome: chr14 Starnd: + Coordinate: Start Site(bp): 101040234 End Site(bp): 101040255 External Links: hsa-miR-654-5p

Disease Information

Disease Name: Prostate Cancer Disease Category: Cancers MeSH ID: D011471 Type: Neoplasms/Digestive System Neoplasms Alias: Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate

Expression Detail

GEO ID: GSE134266 Description: Deep sequencing identified serum extracellular vesicle delivered miR-181a-5p as an indicator for bone-metastatic prostate cancer (microarray) Experimental Design: Cancer vs Control Case Disease Type: Prostate Cancer Case Disease SubType: Bone Metastatic Prostate Cancer Case Sample: Bone Metastatic Prostate Cancer Control Sample: Benign Prostatic Hyperplasia Number of Case: 8 Number of Control: 9 Number of Samples: 17

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand BCL9L chr11 118893875 118925608 - ATP11A chr13 112690329 112887168 + PHB chr17 49404049 49414905 - ZDHHC3 chr3 44915257 44976185 - PKM chr15 72199029 72231822 - ATXN7L3 chr17 44191805 44200113 - SH3PXD2A chr10 103594027 103855543 - ITGA5 chr12 54395261 54419266 - TP53 chr17 7661779 7687550 - CBFA2T3 chr16 88874858 88977207 - CS chr12 56271699 56300391 - LY6E chr8 143017982 143023832 + SPINT1 chr15 40844018 40858207 + AGTRAP chr1 11736084 11754802 + URM1 chr9 128371361 128392016 + BCL7A chr12 122019422 122062044 + MEF2D chr1 156463727 156500779 - DHCR24 chr1 54849627 54887195 - JADE2 chr5 134524312 134583230 + LSM12 chr17 44034328 44067619 - ZMIZ1 chr10 79068966 79316528 + TOB2 chr22 41433494 41446801 - ACTN4 chr19 38647649 38731589 + XPO6 chr16 28097979 28211920 - KMT2D chr12 49018975 49059774 - SMAD3 chr15 67063763 67195169 + BCAM chr19 44809071 44821421 + IGF2BP1 chr17 48997385 49056145 + GID4 chr17 18039408 18068405 + NID1 chr1 235975830 236065109 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000417 chr12 69644908 69656342 + hsa_circ_0000642 chr15 80390757 80415142 + hsa_circ_0000816 chr17 80521229 80526077 + hsa_circ_0000643 chr15 80412669 80415142 + hsa_circ_0000943 chr19 47421744 47440665 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC239868.1 chr1 149861271 149862504 + AL035458.2 chr20 34234840 34281173 - AL356488.2 chr1 109100193 109100619 + NEAT1 chr11 65422774 65445540 + NORAD chr20 36045618 36051018 - OIP5-AS1 chr15 41283990 41309737 + STAG3L5P-PVRIG2P-PILRB chr7 100336104 100367831 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE134266 Sample Source: Blood Source Fraction: Extracellular Vesicle Platform: GPL25134 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2519 Sample treatment protocol: The blood was centrifuged at 2000 g for 10 min at 4 °C to extract the serum. The serum EV was extracted using Total Exosome Isolation Kit (from serum, Thermo fisher scientific). RNA Extract protocol: Exosome Purification and RNA Isolation Kit (Norgen Biotek) was employed to purify EV and extract total RNA in EV consequentially. RNA library preparation protocol: Sample tag and reagents are included in the hybrid need Agilent's micrornas Complete Labeling and Hyb Kit (p/n 5190-0456).

Reference

PMID: NA Title: NA Author: NA Journal: NA Description: NA